Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wenbin Cao
Observed names:
Wen-Bin Cao,
Wen-bin Cao,
Wen‐bin Cao
Institutions:
Chinese Academy of Medical Sciences & Peking Union Medical College,
Institute of Hematology & Blood Diseases Hospital,
State Key Laboratory of Experimental Hematology
Observed institutions:
Chinese Academy of Medical Sciences & Peking Union Medical College,
Institute of Hematology & Blood Diseases Hospital,
State Key Laboratory of Experimental Hematology
ORCID:
0000-0002-5507-1936
Observed ORCID:
0000-0002-5507-1936
OpenAlex ID:
A5037572588
Single-cell transcriptomic landscape of human blood cells
2020
·
Xiaowei Xie
, Mengyao Liu
, et al.
·
National Science Review
·
143
PDF
TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence
2017
·
Ke Li
, Feng Wang
, et al.
·
Cancer Cell
·
108
PDF
Radiation-induced bystander effects impair transplanted human hematopoietic stem cells via oxidative DNA damage
2021
·
Linping Hu
, Xiuxiu Yin
, et al.
·
Blood
·
64
Temporal molecular program of human hematopoietic stem and progenitor cells after birth
2022
·
Yawen Zhang
, Xiaowei Xie
, et al.
·
Developmental Cell
·
39
PDGFB-expressing mesenchymal stem cells improve human hematopoietic stem cell engraftment in immunodeficient mice
2019
·
Xiuxiu Yin
, Linping Hu
, et al.
·
Bone Marrow Transplantation
·
32
PDF
Metagenomic next-generation sequencing diagnosis of peripheral pulmonary infectious lesions through virtual navigation, radial EBUS, ultrathin bronchoscopy, and ROSE
2019
·
Nana Liu
, Jianying Kan
, et al.
·
Journal of International Medical Research
·
25
Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia
2024
·
Feng Wang
, Yunxuan Li
, et al.
·
Nature Communications
·
24
PDF
Bone Marrow-Derived Mesenchymal Stem Cells Modified with Akt1 Ameliorates Acute Liver GVHD
2019
·
Lukun Zhou
, Shuang Liu
, et al.
·
Biological Procedures Online
·
22
PDF
Application of metagenomic next-generation sequencing technology for difficult lung lesions in patients with haematological diseases
2020
·
Nana Liu
, Jianying Kan
, et al.
·
Translational Cancer Research
·
9
PDF
Successful Blinatumomab treatment in an allogeneic hematopoietic stem cell transplant recipient with EBV-related post-transplant lymphoproliferative disorder: A case report and literature review
2023
·
Shulian Chen
, Licai An
, et al.
·
Transplant Immunology
·
7
BCR ‐ ABL enhances the prolyl isomerase activity of Pin 1 by interacting with DAPK 1 in ph+ ALL
2018
·
Wen‐bin Cao
, Jian‐feng Yao
, et al.
·
Cancer Medicine
·
7
PDF
Efficacy and Safety of the Third‐Generation Tyrosine Kinase Inhibitor Olverembatinib in Combination With Inotuzumab Ozogamicin for the Treatment of Adult Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia Patients With Refractory/Relapsed Disease or Persistent Minimal Residual Disease Bridging to Hematopoietic Stem Cell Transplantation
2025
·
Xiaoyu Zhang
, Yigeng Cao
, et al.
·
American Journal of Hematology
·
6
PDF
[Clinical features and antimicrobial resistance of Gram positive bacterial blood stream infection in patients with hematologic diseases].
2012
·
Wen-bin Cao
, Dong Su
, et al.
·
PubMed
·
6
Increased Epstein-Barr virus reactivation but similar incidence of post-transplant lymphoproliferative disorders due to pre-emptive rituximab therapy following allogeneic hematopoietic stem cell transplantation in the letermovir era for cytomegalovirus prophylaxis
2025
·
Sisi Zhen
, Li Liu
, et al.
·
Bone Marrow Transplantation
·
5
Clinical significance of anti-endothelial cell antibody in allogeneic hematopoietic stem cell transplantation recipients with graft-versus-host disease
2014
·
Jianfeng Yao
, Axia Song
, et al.
·
International Journal of Hematology
·
5
Targeting HDAC8 sensitizes tyrosine kinase inhibitors in the elimination of B-cell acute lymphoblastic leukemia cells through degradation of HIF-1α
2025
·
Guilin Xu
, Feng Wang
, et al.
·
Leukemia
·
4
Incidence, Risk Factors, and Outcomes of Bloodstream Infection during Conditioning Phase before Allogeneic Hematopoietic Stem Cell Transplantation
2025
·
Ling Pan
, Jia Li
, et al.
·
Transplantation and Cellular Therapy
·
3
The impact of letermovir prophylaxis in matched sibling donor haematopoietic stem cell transplantation: Selecting the appropriate population for optimal prophylactic therapy
2025
·
Sisi Zhen
, Li Liu
, et al.
·
British Journal of Haematology
·
2
EASIX and sC5b-9 for early identification of adults at high risk of developing TA-TMA after allo-HCT
2026
·
Wenwen Guo
, Shulian Chen
, et al.
·
Bone Marrow Transplantation
·
1
Correction: PDGFB-expressing mesenchymal stem cells improve human hematopoietic stem cell engraftment in immunodeficient mice
2020
·
Xiuxiu Yin
, Linping Hu
, et al.
·
Bone Marrow Transplantation
·
1
PDF
Day + 30 detection of minimal residual FLT3-ITD by high-sensitivity PCR-NGS predicts relapse risk and guides post-transplant maintenance in AML
2026
·
Shan Jiang
, Dan Feng
, et al.
·
BMC Medicine
Impact of prior solid tumor on outcomes of hematopoietic stem cell transplantation for hematologic malignancies: a propensity score-matched study
2026
·
Jieya Luo
, Mingyang Wang
, et al.
·
Frontiers in Immunology
PDF
Thiotepa and Busulfan Combined With Cyclophosphamide Conditioning Regimen Plus Maintenance Therapy Improved the Disease‐Free Survival of Patients With Relapsed/Refractory Hematologic Malignancies After Undergoing Allogeneic Transplantation
2025
·
Shulian Chen
, Rui Cui
, et al.
·
Hematological Oncology
Targeting relapsed/refractory and MRD + Ph + ALL: olverembatinib-venetoclax bridging enhances allo-HSCT outcome
2025
·
Xiaoyu Zhang
, Yanhong Zhao
, et al.
·
Annals of Hematology
PDF
Title: allogeneic peripheral blood stem cell transplantation for Myeloid sarcoma: a single-center experience
2025
·
Dewan Zhao
, Wenbin Cao
, et al.
·
Hematology
PDF
Show more works
View as search
Works count:
35
Citation count:
513
H-index:
9
I10-index:
8
Year
Topic
Type